82 related articles for article (PubMed ID: 35799270)
1. Postoperative recurrent patterns of gallbladder cancer: possible implications for adjuvant therapy.
Yuan Z; Shui Y; Liu L; Guo Y; Wei Q
Radiat Oncol; 2022 Jul; 17(1):118. PubMed ID: 35799270
[TBL] [Abstract][Full Text] [Related]
2. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.
Kim WS; Choi DW; You DD; Ho CY; Heo JS; Choi SH
J Gastrointest Surg; 2010 Apr; 14(4):679-87. PubMed ID: 20094817
[TBL] [Abstract][Full Text] [Related]
3. Interaortocaval Lymph Node Metastasis in Gall Bladder Cancer: Is It Regional Node or Metastatic Disease?
Aggarwal A; Goel S; Sayed AI; Goel V; Talwar V; Singh S
J Gastrointest Cancer; 2023 Dec; 54(4):1252-1260. PubMed ID: 36729244
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancer.
Shukla P; Mishra K; Shukla R; Vishwakarma R; Kumari N; Krishnani N; Behari A; Kapoor VK
J Cancer Res Ther; 2024 Jan; 20(1):349-357. PubMed ID: 38554345
[TBL] [Abstract][Full Text] [Related]
5. The significance of countable and treatable metastatic liver disease in patients with gallbladder carcinoma after curative-intent surgery: A 10-year experience in China.
Lv TR; Liu F; Ma WJ; Hu HJ; Jin YW; Li FY
Cancer Med; 2023 Sep; 12(18):18503-18515. PubMed ID: 37563921
[TBL] [Abstract][Full Text] [Related]
6. Benefit of adjuvant radiotherapy for gallbladder cancer: a comparability-based meta-analysis.
Choi SH; Rim CH; Shin IS; Yoon WS; Koom WS; Seong J
Hepatol Int; 2022 Jun; 16(3):712-727. PubMed ID: 35532861
[TBL] [Abstract][Full Text] [Related]
7. Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer.
Kattepur AK; Patkar S; Goel M; Ramaswamy A; Ostwal V
J Gastrointest Surg; 2019 Nov; 23(11):2232-2238. PubMed ID: 30706378
[TBL] [Abstract][Full Text] [Related]
8. Surgical Strategy for T2 Gallbladder Cancer: Nationwide Multicenter Survey in Korea.
Lee SE; Kim SW; Han HS; Lee WJ; Yoon DS; Cho BH; Choi IS; Kim HJ; Hong SC; Lee SM; Choi DW; Park SJ; Kim HJ; Jang JY;
J Korean Med Sci; 2018 Jul; 33(28):e186. PubMed ID: 29983693
[TBL] [Abstract][Full Text] [Related]
9. Practice patterns in diagnostics, staging, and management strategies of gallbladder cancer among Nordic tertiary centers.
Takala S; Lassen K; Søreide K; Sparrelid E; Angelsen JH; Bringeland EA; Eilard MS; Hemmingsson O; Isaksson B; Karjula H; Lammi JP; Larsen PN; Lavonius M; Lindell G; Mortensen FV; Mortensen K; Nordin A; Pless T; Sandström P; Sandvik O; Vaalavuo Y; Villard C; Sallinen V
Scand J Surg; 2023 Sep; 112(3):147-156. PubMed ID: 37377127
[TBL] [Abstract][Full Text] [Related]
10. Fatty Acid Binding Protein 1 is an Independent Prognostic Biomarker for Gallbladder Cancer with Direct Hepatic Invasion.
Qiu S; Liu Z; Hu J; Wang Z; Yue Z; Jia Z; Zhang W; Xue Z; Liu Z; Liu Y
Int J Med Sci; 2024; 21(5):862-873. PubMed ID: 38617005
[No Abstract] [Full Text] [Related]
11. Impact of ABCB1 and ABCG2 Transporter in Outcome of Gallbladder Cancer.
Nimisha ; Saluja SS; Sharma AK; Nekarakanti PK; Apurva ; Kumar A; Ahmad E; Husain SA
J Clin Exp Hepatol; 2024; 14(5):101410. PubMed ID: 38716375
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum MMP-1 associated with advanced disease stage and lymph node metastasis in patients with pancreatic carcinoma.
Xu X; Ji H; Guo Z; Lu X
Am J Cancer Res; 2023; 13(11):5405-5417. PubMed ID: 38058827
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Recurrence After Primary Local Therapy for Pancreatic Ductal Adenocarcinoma - A Critical Review of Rationale and Target Delineation for (Neo)Adjuvant Radiation Therapy.
Jethwa KR; Neibart SS; Truty MJ; Jabbour SK; Hallemeier CL
Pract Radiat Oncol; 2022; 12(6):e463-e473. PubMed ID: 35718073
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of adjuvant therapy after radical surgery for primary osteosarcoma of the jaws.
Wu S; Wang Y; Zhang J; He Z; Sun Y; Ye M
Wien Klin Wochenschr; 2023 Sep; 135(17-18):488-495. PubMed ID: 37308792
[TBL] [Abstract][Full Text] [Related]
15. Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy.
Koo TR; Eom KY; Kim IA; Cho JY; Yoon YS; Hwang DW; Han HS; Kim JS
Radiat Oncol J; 2014 Jun; 32(2):63-9. PubMed ID: 25061574
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for resected cases with gallbladder carcinoma: A systematic review and meta-analysis.
Lv TR; Wang JK; Li FY; Hu HJ
Int J Surg; 2024 Mar; ():. PubMed ID: 38537060
[TBL] [Abstract][Full Text] [Related]
17. A new staging system for postoperative prognostication in pancreatic ductal adenocarcinoma.
Liang Y; Cui J; Ding F; Zou Y; Guo H; Man Q; Chang S; Gao S; Hao J
iScience; 2023 Sep; 26(9):107589. PubMed ID: 37664604
[TBL] [Abstract][Full Text] [Related]
18. Improved long-term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancer.
Jia ZY; Zhu YD; Wu XS; Yang JX; Wu WG; Wang XA; He M; Wang H; Yang LH; Zhang J; Li XC; Zou L; Li HF; Zhang F; Bao RF; Cui XY; Song XL; Chen W; Gong W; Li ML; Liu YB
Cancer Med; 2023 Sep; 12(18):18861-18871. PubMed ID: 37706628
[TBL] [Abstract][Full Text] [Related]
19. Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for distal cholangiocarcinoma: An international multicentre retrospective cohort study.
Labib PL; Russell TB; Denson JL; Puckett MA; Ausania F; Pando E; Roberts KJ; Kausar A; Mavroeidis VK; Bhogal RH; Marangoni G; Thomasset SC; Frampton AE; Spalding DR; Lykoudis P; Bellotti R; Alhaboob N; Srinivasan P; Bari H; Smith A; Dominguez-Rosado I; Croagh D; Thakkar RG; Gomez D; Silva MA; Lapolla P; Mingoli A; Davidson BR; Porcu A; Shah NS; Hamady ZZ; Al-Sarireh BA; Serrablo A; ; Aroori S
Eur J Surg Oncol; 2024 Apr; 50(6):108353. PubMed ID: 38701690
[TBL] [Abstract][Full Text] [Related]
20. Unraveling early recurrence of risk factors in Gallbladder cancer: A systematic review and meta-analysis.
Yang SQ; Feng H; Tian Y; Zou RQ; Dai YS; Hu HJ; Li FY
Eur J Surg Oncol; 2024 Apr; 50(7):108372. PubMed ID: 38718620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
